Silicon Republic July 29, 2020
Jenny Darmody

Prof Kurt Zatloukal spoke to Siliconrepublic.com about genome sequencing and the difference between research and healthcare settings.

Medical genomics and next-generation sequencing may be a major game changer in healthcare and diagnostics. By using the knowledge of an individual’s genomic make-up to identify those with higher risks of certain conditions, it could enable healthcare professionals to intervene at earlier stages.

Couple this with pharmacogenetic testing, which shows how a person’s genes affect their body’s response to certain medicines, and the way in which patients are treated in the future could be life changing.

With this in mind, there are currently two projects in the EU each receiving approximately €11m in funding as part of the Horizon 2020 framework, which aim...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Regulations
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article